Correction: Immunotherapy of ovarian cancer with a monoclonal antibody specific for the extracellular domain of anti-Müllerian hormone receptor II.

Autor:	Mazumder S; Department of Inflammation and Immunity, Lerner Research Institute, Cleveland Clinic, Cleveland, OH, USA.; Department of Molecular Medicine, Cleveland Clinic Lerner College of Medicine of Case Western Reserve University, Cleveland, OH, USA.; Case Comprehensive Cancer Center, Cleveland, OH, USA., Swank V; Department of Inflammation and Immunity, Lerner Research Institute, Cleveland Clinic, Cleveland, OH, USA., Komar AA; Department of Biological, Geological and Environmental Sciences, Cleveland State University, Cleveland, OH, USA.; Center for Gene Regulation in Health and Disease, Cleveland State University, Cleveland, OH, USA., Johnson JM; Department of Inflammation and Immunity, Lerner Research Institute, Cleveland Clinic, Cleveland, OH, USA.; Department of Biological, Geological and Environmental Sciences, Cleveland State University, Cleveland, OH, USA., Tuohy VK; Department of Inflammation and Immunity, Lerner Research Institute, Cleveland Clinic, Cleveland, OH, USA.; Department of Molecular Medicine, Cleveland Clinic Lerner College of Medicine of Case Western Reserve University, Cleveland, OH, USA.; Case Comprehensive Cancer Center, Cleveland, OH, USA.; Department of Biological, Geological and Environmental Sciences, Cleveland State University, Cleveland, OH, USA.
Jazyk:	angličtina
Zdroj:	Oncotarget [Oncotarget] 2022 Jul 28; Vol. 13, pp. 905-906. Date of Electronic Publication: 2022 Jul 28 (Print Publication: 2022).
DOI:	10.18632/oncotarget.28246
Abstrakt:	[This corrects the article DOI: 10.18632/oncotarget.27585.]. (Copyright: © 2022 Mazumder et al.)
Databáze:	MEDLINE
Externí odkaz:	Zobrazit plný text záznamu